🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Fibrosis

Spleen Stiffness Measurement for the Detection of Advanced Fibrosis NCT07440511n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis NCT07809867Phase 41 site📍 Genova Istituto Giannina Gaslini · Tests: Elexacaftor, Tezacaftor, Ivacaftor, Ivacaftor (VX-770) Faecal Microbiota Transplantation for Liver Cirrhosis NCT04932577Phase 2, Phase 31 site📍 Aarhus University of Aarhus · Tests: Faecal microbiota transplantation, Placebo The Development of MASLD Among Survivors of Breast or Colorectal Cancer NCT07280143n/a1 site📍 Bern University of Bern Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention NCT07010315n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Cognitive Testing, Usability Testing A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their Offspring NCT06797206n/a1 site📍 London Royal Brompton & Harefield NHS Foundation Trust 3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features NCT06955208NA1 site📍 Shenyang Shengjing Hospital · Tests: Magnetic Resonance Elastography, Intraoperative Assessment and Recording Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases NCT06537934n/a1 site📍 Milan IRCCS San Raffaele Effectiveness of Bariatric Surgery for NAFLD/NASH NCT04366999n/a1 site📍 Beijing Beijing Friendship Hospital · Tests: SG, RYGB, OAGB Study of the Prevalence of Active/Passive Smoking and Vaping Among Patients With Cystic Fibrosis NCT07342920n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Estrogen Supplementation and Bone Health in Women With CF NCT05704036Phase 41 site📍 Baltimore Johns Hopkins University · Tests: Transdermal estrogen, Progesterone VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS) NCT07390344n/a3 sites📍 Atlanta📍 Minneapolis📍 Cleveland W.L.Gore & Associates · Tests: GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion (6-10mm) Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis NCT05310669n/a1 site📍 Modena University of Modena and Reggio Emilia · Tests: Nasal pressure assessment Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site📍 Shanghai Ruijin Hospital · Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually Endoscopic Stricturotomy Versus Balloon Dilation for Small Bowel Fibrotic Strictures in Crohn's Disease NCT07833332NA1 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Endoscopic Stricturotomy, Endoscopic Balloon Dilation Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies NCT01776398n/a1 site📍 New York Weill Medical College of Cornell University Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study NCT05974904n/a1 site📍 Chongqing Chongqing Medical University · Tests: high-sensitivity C-reactive protein to albumin ratio Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF NCT06655480Phase 21 site📍 Moscow National Medical Research Center for Cardiology, Ministry o… · Tests: [ARNI + SGLTi + AMR], [SGLTi + previously taken RAAS blocker] Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury NCT04485286Phase 21 site📍 Boston Massachusetts General Hospital · Tests: [68Ga]CBP8 A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis NCT07291141n/a1 site📍 Linköping Mattias Ekstedt AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF NCT07194382Phase 249 sites📍 Camperdown📍 Kingswood📍 New Lambton Heights Avalyn Pharma Inc. · Tests: AP02, Placebo Impact of Liver Transplantation on Sexual Life and Function NCT07268196n/a1 site📍 New Delhi Institute of Liver and Biliary Sciences, India · Tests: No Treatment CF Wellness Program NCT07071324NA3 sites📍 Denver📍 Baltimore📍 Boston Johns Hopkins University · Tests: CF Wellness Program Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient Elastography NCT07128108n/a1 site📍 Shanghai Xinhua Hospital, Shanghai Jiao Tong University School of Me… · Tests: Visual Transient Elastography (ViTE) Examination A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions NCT06864195n/a1 site📍 London Imperial College London EGCG for Hepatocellular Carcinoma Chemoprevention NCT06015022Phase 21 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Epigallocatechin gallate (EGCG), Placebo Liver Damage and Cardiometabolic Disorders in NAFLD NCT04036357n/a1 site📍 Rome University of Roma La Sapienza A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients NCT05139719Phase 21 site📍 Beijing Sunshine Lake Pharma Co., Ltd. · Tests: HEC585 dose A, HEC585 dose B, Placebo Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis NCT06602869n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Scheduled visit (V1) Comprehensive Esophageal Diagnostics Study NCT04641702Phase 42 sites📍 Atlanta📍 Atlanta Emory University · Tests: Atropine challenge, Esophageal muscle biopsy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy